A 23-year-old CVS employee was killed on Thursday in Lindenhurst, the authorities said. Police were searching for a suspect in his 40s who fled on foot.

The blueprint covers a broad range of issues, including territory, security guarantees and postwar reconstruction. But Russia has indicated little willingness to end the war.

Zohran Mamdani’s campaign encouraged canvassers to ditch their scripts in pursuit of genuine, off-the-cuff-conversation. It’s a strategy that some Democratic strategists want to see more of.

The far-right group known as the R.S.S., whose members include Prime Minister Narendra Modi, has spent a century trying to make India a Hindu-first nation.

Mayor-elect Zohran Mamdani’s signature plans for New York City will take time. Lina Khan, the former chair of the Federal Trade Commission, has ideas for making a swift impact.

Artificial intelligence companies looking to raise funds are being made to pay lofty interest rates, as debt investors become cautious.

Shoes. A phone. Receipts. A comb. Traces of wild nights and hurried days are all around us.

After Israel sealed Gaza’s borders, Hoda Abu al-Naja, 12, who suffered from celiac disease, spent months seeking the food and care she needed to combat malnutrition.

Daniel DiDonato, 19, has loved elections since he was in fourth grade. He also loves maps.

She went on testosterone to help with her menopausal symptoms. The effects had unexpected consequences for their marriage.

Megacities in southern India are attracting enormous investments to help build artificial intelligence infrastructure to serve the world’s most data-hungry country.

The passage of Proposition 50, which redrew California’s congressional map, means that all of the state’s conservative north is likely to be represented by Democrats.

As many as 25,000 free-ranging dogs roam the cold, high-altitude desert of Ladakh, India. That’s a problem for wildlife and people alike.

The number of patients going to hospital emergency rooms with flulike symptoms has soared.

There is no F.D.A.-approved testosterone product for women. Insurance won’t cover it. Many doctors won’t prescribe it. It’s become a cultural phenomenon.